InvestorWire NewsRoom


Diversity in Clinical Trials Summit Underscores Need for Targeting More Broadly Representative Patient Populations
May 18, 2022

Diversity in Clinical Trials Summit Underscores Need for Targeting More Broadly Representative Patient Populations

The Diversity in Clinical Trials Summit presented by Dynamic Global Events (“DGE”) in June is an unequaled venue for your team to establish strategies ensuring that a diversity of patient populations are represented in the testing of new drug products. 

A key element of conducting sound trials is ensuring that minority populations are included in the testing because they will comprise a portion of the affected patient profile, and may have unique responses to the trials.  But historically, clinical trials have excluded and overlooked them.   

The Diversity in Clinical Trials Summit aims to re-center drug development around patient diversity in order to improve health outcomes through equitable approaches

Key takeaways: 

  • Develop long-term relationships of trust with external partners 
  • Learn how decentralized testing can improve diverse representation in clinical trials
  • Gain greater awareness of the importance of diversity, equity and inclusion across the biopharma industry
  • Learn to build better patient outcomes through collaborative networks in clinical testing
  • Understand the impact of the Clinical Treatment Act on representative patient populations

Education and Opportunity:

DGE is a life science leader experienced in organizing B2B events with a focus on the informational and networking needs of professionals within health-related industries such as pharmaceutical, biotechnology, medical devices and the healthcare treatment sector.

For more information about this event, please visit

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).